You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Dermatology
On demand events
EAACI 2023 Symposium: Targeting Type 2 Inflammation in Children With Atopic Dermatitis: Opportunity for Early Intervention?
Presentations from the ADVENT symposium at the EAACI 2023 congress on targeting type 2 Inflammation in children with atopic dermatitis.
MD, PhD
Stephan Weidinger +2 more
On demand materials
Learning objectives
- Examine the multidimensional disease burden in children with AD and their families/caregivers, and the impact of type 2 comorbidities
- Learn about the impact of targeting type 2 inflammation in children with AD, from the normalization of the skin barrier to the improvement of bone mineralization markers
- Provide an overview of the treatment landscape in children with AD and examine updates on clinical trials of dupilumab
Description
In this ADVENT symposium at the 2023 EAACI congress, “Targeting Type 2 Inflammation in Children With Atopic Dermatitis: Opportunity for Early Intervention?”, Stephan Weidinger, MD, PhD (University Hospital Schleswig-Holstein), Peter Arkwright, MD, PhD (University of Manchester), and Oscar Palomares, PhD (University of Madrid), discussed the multidimensional disease burden of atopic dermatitis in children, the pathophysiology of the disease driven by type 2 inflammation, and the current treatment landscape for pediatric patients with atopic dermatitis.
Tags
MAT-GLB-2302884 V2
About these experts
